[1] Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415(6870):389-95.

[2] Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006; 18(1): 24-30.

[3] Nizet V, Ohtake T, Lauth X et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414(6862): 454-7.

[4] Chromek M, Slamova Z, Bergman P et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 2006; 12(6):636-641.

[5] Moser C, Weiner DJ, Lysenko E et al. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002; 70(6):3068-72.

Lehrer R, Ganz T, Selsted M. Defesins: endogenous antibiotic peptides of animal cells. Cell 1991; 64:229-230.

Goldman MJ, Anderson GM, Stolzenberg ED et al. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997; 88(4):553-60. McCray PJ, Bentley L. Human airway epithelia express a beta-defensin. Am J Respir Cell Mol Biol 1997; 16(3):343-349.

Diamond G, Zasloff M, Eck H et al. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 1991; 88:3952-3956.

Bals R, Wang X, Wu Z et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998; 102:874-880.

Harder J, Bartels J, Christophers E et al. A peptide antibiotic from human skin. Nature 1997; 387:861.

Koczulla AR, Bals R. Antimicrobial peptides: current status and therapeutic potential. Drugs 2003; 63(4):389-406.

Beisswenger C, Bals R. Antimicrobial peptides in lung inflammation. Chem Immunol Allergy 2005; 86: 55-71.

Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1(3):141-150.

Bals R, Wang X, Zasloff M et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A 1998; 95(16):9541-9546.

Yang D, Biragyn A, Hoover DM et al. Multiple Roles of Antimicrobial Defensins, Cathelicidins, and Eosinophil-Derived Neurotoxin in Host Defense. Annu Rev Immunol 2004; 22:181-215. Heilborn JD, Nilsson MF, Kratz G et al. The cathelicidin anti-microbial peptide LL-37 is involved in re- epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003; 120(3):379-389.

Shaykhiev R, Beisswenger C, Kaendler K et al. The human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005; 289(5):842-848.

Agerberth B, Gunne H, Odeberg J et al. PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpart. Veterinary Immunology & Immunopathology 1996; 54(1-4):127-31.

Koczulla R, von Degenfeld G, Kupatt C et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111(11):1665-72.

Yang D, Chen Q, Schmidt AP et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T-cells. J Exp Med 2000; 192(7):1069-74. Steinstraesser L, Ring A, Bals R et al. The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers. Ann Plast Surg 2006; 56(1): 93-98. Li J, Post M, Volk R et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000; 6(1): 49-55. Conejo-Garcia JR, Benencia F, Courreges MC et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 2004; 10(9):950-958.

Svendsen MN, Werther K, Nielsen HJ et al. VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion. Scand J Gastroenterol 2002; 37(4):373-379. Peyssonnaux C, Datta V, Cramer T et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005; 115(7):1806-1815.

Heilborn JD, Nilsson MF, Jimenez CI et al. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 2005; 114(5):713-719.

Was this article helpful?

0 0

Post a comment